Safety and efficacy of caproamin fides and tranexamic Acid versus placebo in patients undergoing coronary artery revascularization.

Alizadeh Ghavidel, Alireza; Totonchi, Ziae; Chitsazan, Mitra; Gholampour Dehaki, Maziar; Jalili, Farshid; Farsad, Fariborz; Hejrati, Maral

Alizadeh Ghavidel, Alireza; Totonchi, Ziae; Chitsazan, Mitra; Gholampour Dehaki, Maziar; Jalili, Farshid; Farsad, Fariborz; Hejrati, Maral.

Afiliação

Alizadeh Ghavidel A; Heart Valve Disease Research Center, Rajaei Cardiovascular Medical and Research Center, Iran University of Medical Science, Tehran, Iran.
Totonchi Z; Rajaei Cardiovascular Medical and Research Center, Iran University of Medical Science, Tehran, Iran.
Chitsazan M; Heart Valve Disease Research Center, Rajaei Cardiovascular Medical and Research Center, Iran University of Medical Science, Tehran, Iran.
Gholampour Dehaki M; Heart Valve Disease Research Center, Rajaei Cardiovascular Medical and Research Center, Iran University of Medical Science, Tehran, Iran.
Jalili F; Rajaei Cardiovascular Medical and Research Center, Iran University of Medical Science, Tehran, Iran.
Farsad F; Rajaei Cardiovascular Medical and Research Center, Iran University of Medical Science, Tehran, Iran.
Hejrati M; Rasoul-e-Akram General Hospital, Iran University of Medical Sciences, Tehran, Iran.

J Cardiovasc Thorac Res ; 6(3): 197-202, 2014.

Article em En | MEDLINE | ID: mdl-25320669

Palavras-chave

Aminocaproic acid; Antifibrinolytic agents; Coronary artery bypass; Tranexamic acid

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: J Cardiovasc Thorac Res Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Irã País de publicação: Irã

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google